{'fraction_non_alphanumeric': 0.025222551928783383, 'fraction_numerical': 0.008902077151335312, 'mean_word_length': 5.617647058823529, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Retraction of: Association Between ApoA-I (Apolipoprotein A-I) Immune Complexes and Adverse Cardiovascular Events.

After publication, the authors identified misinterpreted data that impacts the conclusion of the article that apolipoprotein A-I and IgG immune complexes are inversely associated with disease progression. Although the observed association with disease outcomes remains, the authors have strong evidence that the analyte measured is not apolipoprotein A-I and IgG immune complexes. Therefore, the authors have requested to retract the article. HHS Public Access Author manuscript Arterioscler Thromb Vasc Biol. Author manuscript; available in PMC 2021 May 06.